Exposure to LPS in the range of 50 to 250 pg/mL induced cell viability of AML cells in a dose-dependent manner in both FLT3-ITD-positive MOLM-13 (Figure 1B) and FLT3 wild-type ML-2 cells (Figure 1C). The gene discussed is FLT3; the disease is acute myeloid leukemia.